{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:34:26Z","timestamp":1787236466433,"version":"build-2736575974"},"reference-count":18,"publisher":"Royal College of General Practitioners","issue":"605","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Gen Pract"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.3399\/bjgp12x659277","type":"journal-article","created":{"date-parts":[[2012,11,26]],"date-time":"2012-11-26T21:10:18Z","timestamp":1353964218000},"page":"e808-e814","source":"Crossref","is-referenced-by-count":13,"title":["Prescription of antiviral therapy after herpes zoster in general practice: who receives therapy?"],"prefix":"10.3399","volume":"62","author":[{"given":"Harriet J","family":"Forbes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara L","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam","family":"Smeeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sin\u00e9ad M","family":"Langan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1987","published-online":{"date-parts":[[2012,12,1]]},"reference":[{"issue":"5","key":"2018072011031365000_62.605.e808.1","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJMcp013211","article-title":"Clinical practice","volume":"347","author":"Gnann","year":"2002","journal-title":"Herpes zoster. N Engl J Med"},{"issue":"1","key":"2018072011031365000_62.605.e808.2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1473-3099(03)00857-0","article-title":"What does epidemiology tell us about risk factors for herpes zoster?","volume":"4","author":"Thomas","year":"2004","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"2018072011031365000_62.605.e808.3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1017\/S0950268808000678","article-title":"Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom","volume":"137","author":"Gauthier","year":"2009","journal-title":"Epidemiol Infect"},{"issue":"Suppl 1","key":"2018072011031365000_62.605.e808.4","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/510206","article-title":"Recommendations for the management of herpes zoster","volume":"44","author":"Dworkin","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"2","key":"2018072011031365000_62.605.e808.5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7326\/0003-4819-123-2-199507150-00002","article-title":"Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group","volume":"123","author":"Tyring","year":"1995","journal-title":"Ann Intern Med"},{"issue":"2","key":"2018072011031365000_62.605.e808.6","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/clinids\/22.2.341","article-title":"Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials","volume":"22","author":"Wood","year":"1996","journal-title":"Clin Infect Dis"},{"key":"2018072011031365000_62.605.e808.7","doi-asserted-by":"crossref","unstructured":"Li Q Chen N Yang J (2009) Antiviral treatment for preventing postherpetic neuralgia. Cochrane Database Syst Rev (2):CD006866.","DOI":"10.1002\/14651858.CD006866.pub2"},{"key":"2018072011031365000_62.605.e808.8","unstructured":"Clinical Knowledge Summaries Shingles \u2014 management. When should I prescribe an antiviral drug? CKS, 2012. http:\/\/www.cks.nhs.uk\/shingles\/management\/scenario_shingles\/when_to_prescribe_an_antiviral_drug\/basis_for_recommendation#-338090 (accessed 31 Oct 2012)."},{"issue":"7","key":"2018072011031365000_62.605.e808.9","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/pds.1115","article-title":"The relationship between time since registration and measured incidence rates in the General Practice Research Database","volume":"14","author":"Lewis","year":"2005","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2018072011031365000_62.605.e808.10","unstructured":"Noble M McLennan D Wilkinson K (2008) The English Indices of Deprivation 2007 (Communities and Local Government, London)."},{"issue":"1","key":"2018072011031365000_62.605.e808.11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1468-3083.2000.00020.x","article-title":"Factors influencing pain outcome in herpes zoster: an observational study with valaciclovir","volume":"14","author":"Decroix","year":"2000","journal-title":"Valaciclovir International Zoster Assessment Group (VIZA). J Eur Acad Dermatol Venereol"},{"issue":"1","key":"2018072011031365000_62.605.e808.12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/147323000203000109","article-title":"Clinical correlates of prolonged pain in Japanese patients with acute herpes zoster","volume":"30","author":"Kurokawa","year":"2002","journal-title":"J Int Med Res"},{"issue":"9","key":"2018072011031365000_62.605.e808.13","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.vaccine.2005.09.026","article-title":"The burden of herpes zoster: a prospective population based study","volume":"24","author":"Scott","year":"2006","journal-title":"Vaccine"},{"issue":"9334","key":"2018072011031365000_62.605.e808.14","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0140-6736(02)09837-9","article-title":"Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study","volume":"360","author":"Thomas","year":"2002","journal-title":"Lancet"},{"key":"2018072011031365000_62.605.e808.15","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/1471-2334-10-230","article-title":"Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study","volume":"10","author":"Gialloreti","year":"2010","journal-title":"BMC Infect Dis"},{"issue":"4","key":"2018072011031365000_62.605.e808.16","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.vaccine.2008.11.012","article-title":"Herpes zoster burden of illness and health care resource utilisation in the Australian population aged 50 years and older","volume":"27","author":"Stein","year":"2009","journal-title":"Vaccine"},{"issue":"2","key":"2018072011031365000_62.605.e808.17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2165\/00019053-200725020-00007","article-title":"Acute\/subacute herpes zoster: healthcare resource utilisation and costs in a group of US health plans","volume":"25","author":"Insinga","year":"2007","journal-title":"Pharmacoeconomics"},{"issue":"5","key":"2018072011031365000_62.605.e808.18","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/fampra\/cmi055","article-title":"Do herpes zoster patients receive antivirals? A Dutch National Survey in General Practice","volume":"22","author":"Opstelten","year":"2005","journal-title":"Fam Pract"}],"container-title":["British Journal of General Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3399\/bjgp12X659277","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T14:33:10Z","timestamp":1645799590000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjgp.org\/lookup\/doi\/10.3399\/bjgp12X659277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":18,"journal-issue":{"issue":"605","published-online":{"date-parts":[[2012,12,1]]},"published-print":{"date-parts":[[2012,12]]}},"alternative-id":["10.3399\/bjgp12X659277"],"URL":"https:\/\/doi.org\/10.3399\/bjgp12x659277","relation":{},"ISSN":["0960-1643","1478-5242"],"issn-type":[{"value":"0960-1643","type":"print"},{"value":"1478-5242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}